CIURLEO, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.613
EU - Europa 1.263
AS - Asia 1.239
SA - Sud America 456
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 9.603
Nazione #
US - Stati Uniti d'America 6.567
SG - Singapore 494
BR - Brasile 393
CN - Cina 360
SE - Svezia 338
IE - Irlanda 327
HK - Hong Kong 166
DE - Germania 122
IT - Italia 117
UA - Ucraina 104
VN - Vietnam 95
FI - Finlandia 63
RU - Federazione Russa 55
GB - Regno Unito 44
IN - India 28
AR - Argentina 22
CA - Canada 21
FR - Francia 19
MX - Messico 19
BD - Bangladesh 18
AT - Austria 15
NL - Olanda 12
PL - Polonia 12
IQ - Iraq 11
CO - Colombia 10
BE - Belgio 9
JP - Giappone 9
TR - Turchia 9
MA - Marocco 8
VE - Venezuela 8
PY - Paraguay 7
EC - Ecuador 6
IL - Israele 5
TN - Tunisia 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CI - Costa d'Avorio 4
ID - Indonesia 4
OM - Oman 4
PK - Pakistan 4
UY - Uruguay 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
ES - Italia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
VC - Saint Vincent e Grenadine 1
Totale 9.603
Città #
Dallas 4.698
Dublin 327
Chandler 315
Ashburn 264
Nyköping 222
Singapore 209
Jacksonville 193
Hong Kong 164
Beijing 138
Dearborn 87
Princeton 56
The Dalles 56
New York 55
Dong Ket 52
Medford 49
Los Angeles 47
Cambridge 46
Boardman 43
Des Moines 43
Messina 33
Munich 31
Buffalo 27
Jinan 23
São Paulo 21
Ann Arbor 18
Nanjing 18
Redondo Beach 18
Hebei 17
Moscow 16
Ho Chi Minh City 14
Rio de Janeiro 13
Vienna 13
Milan 12
Wilmington 12
Woodbridge 12
Bremen 11
Tianjin 11
Belo Horizonte 10
Taiyuan 10
Turku 10
Warsaw 10
Brussels 9
Hanoi 9
Tokyo 9
Brooklyn 8
Catania 8
Chennai 8
Curitiba 8
Frankfurt am Main 8
Hyderabad 8
Santa Clara 8
Taizhou 8
Columbus 7
Lancaster 7
London 7
Seattle 7
Washington 7
Boston 6
Campinas 6
Changsha 6
Montréal 6
Salvador 6
Shenyang 6
Stockholm 6
Amsterdam 5
Asunción 5
Brasília 5
Chicago 5
Contagem 5
Helsinki 5
Houston 5
Montreal 5
Nanchang 5
Piracicaba 5
Poplar 5
Tashkent 5
Abidjan 4
Atlanta 4
Denver 4
Dhaka 4
Fuzhou 4
Haikou 4
Hefei 4
Joinville 4
Lappeenranta 4
Natal 4
Newark 4
Niterói 4
Nuremberg 4
San Mateo 4
Toronto 4
West Jordan 4
Zhengzhou 4
Amman 3
Ankara 3
Baghdad 3
Biên Hòa 3
Casablanca 3
Caxias do Sul 3
City of London 3
Totale 7.741
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 4.727
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 156
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 145
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 134
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 130
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 129
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 129
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 127
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 124
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 120
Functional evaluation of awareness in vegetative and minimally conscious state 115
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 114
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 110
Functional connectivity in vegetative state patients 102
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 102
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 100
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 98
Neurophysiological approach in comatose patients 97
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 95
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 93
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 91
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 90
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 88
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 88
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 84
White matter substrates of functional connectivity dynamics in the human brain 83
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 82
Reality orientation therapy (ROT) in Alzheimer’s disease. 81
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 80
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 79
Evaluation of olfactory dysfunction in neurodegenerative diseases. 79
Evaluation of olfactory dysfunction in neurodegenerative diseases 76
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 75
The role of brain oscillations in post-stroke motor recovery: an overview 73
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 73
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 69
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 69
Neurogenic ejaculatory disorders: focus on current and future treatments. 69
The clinical use of quality of life scales in the neurodegenerative diseases 68
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 68
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 67
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 65
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 65
Transcriptomic data analysis reveals a down-expression of galectin-8 in schizophrenia hippocampus 65
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 64
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 64
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 63
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 63
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 61
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 60
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 60
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 58
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 58
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 54
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 49
Role of statins in the treatment of multiple sclerosis 49
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 47
null 37
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 30
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 24
Identification of common pathogenetic processes between schizophrenia and diabetes mellitus by systems biology analysis 21
Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus 15
Totale 9.651
Categoria #
all - tutte 24.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 38 0 18 1 32 21 66
2021/2022334 2 24 7 8 31 1 55 6 8 15 48 129
2022/20231.122 95 114 44 97 92 124 27 56 425 8 28 12
2023/2024312 21 45 22 35 30 96 1 20 2 14 6 20
2024/20251.204 7 15 38 67 46 24 31 265 331 86 90 204
2025/20265.744 142 1.505 3.402 334 334 27 0 0 0 0 0 0
Totale 9.651